Estimates of the eligible population for Australia’s targeted National Lung Cancer Screening Program, 2025-2030

Author:

Wade StephenORCID,Ngo PrestonORCID,He YueORCID,Caruana MichaelORCID,Steinberg JuliaORCID,Luo QingweiORCID,David MichaelORCID,McWilliams AnnetteORCID,Fong Kwun MORCID,Canfell KarenORCID,Weber MarianneORCID

Abstract

AbstractAustralia’s National Lung Cancer Screening Program will commence in July 2025, targeted at individuals aged 50-70 years with a 30 pack-year smoking history, who either currently smoke or have quit within the last 10 years. We forecasted the number of screening-eligible individuals over the first 5 years of the program using data from the 2019 National Drug Strategy Household Survey, and the 2022 Australian Bureau of Statistics population projections. Multiple imputation integrated with predictive modelling of future or unmeasured smoking characteristics was used to address missing data and simultaneously, to project individuals’ smoking histories to 2030. In 2025, 930,500 (95% prediction interval 852,200-1,019,000) individuals were estimated to be eligible, with the number meeting the criteria declining slightly over the years 2025-2030 in all Australian jurisdictions. Overall, 26-30% of those eligible will have quit smoking, and 70-74% will currently smoke. These estimates can be used in resource planning and as an indicative denominator to track participation rates for the program over time.

Publisher

Cold Spring Harbor Laboratory

Reference18 articles.

1. Cancer Australia. Lung Cancer Screening, https://www.canceraustralia.gov.au/about-us/lung-cancer-screening (accessed 6 May 2024).

2. Australian Institute of Health and Welfare. National Drug Strategy Household Survey 2019. Drug Statistics series no. 32. PHE 270. Canberra, ACT: AIHW, 2020.

3. Australian Bureau of Statistics. Population projections, Australia, 2022 (base) - 2071, https://www.abs.gov.au/statistics/people/population/population-projections-australia/2022-base-2071#data-downloads (2018, accessed 5 June 2024).

4. Survey sampling. by Leslie Kish | Open Library, https://openlibrary.org/books/OL5947497M/Survey_sampling. (accessed 21 June 2024).

5. Estimating eligibility for lung cancer screening in an Australian cohort, including the effect of spirometry;Med J Aust,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3